Multimodal intervention approach shows promise in managing and reversing cognitive impairment

Dr. Heather Sandison, a leading expert in Alzheimer’s Disease and Related Dementia (ADRD) care, has recently published a groundbreaking study in the Journal of Alzheimer’s Disease, highlighting significant improvements in cognitive function among individuals with cognitive decline.

FDA advisers unanimously recommend approval of Eli Lilly’s Alzheimer’s disease treatment

Advisers to the Food and Drug Administration voted 11-0 on Monday to recommend the approval of a drug for early Alzheimer’s disease made by Eli

June 10, 2024

JD Vance talked about reinsurance during the VP debate. How does it work?

WASHINGTON — During the vice presidential debate Tuesday, Republican nominee JD Vance at long last provided a bit more clarity to the Trump campaign’s vague

October 3, 2024

Injected form of Leqembi appears effective at clearing amyloid, but with notable risks

New data on an injectable form of Eisai’s Alzheimer’s drug Leqembi showed that it was more effective than an intravenous version at clearing amyloid, but

October 26, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.